American Portfolios Advisors Regeneron Pharmaceuticals, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 297 shares of REGN stock, worth $208,725. This represents 0.01% of its overall portfolio holdings.

Number of Shares
297
Holding current value
$208,725
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$573.97 - $724.32 $170,469 - $215,123
297 New
297 $205 Million
Q2 2022

Mar 20, 2023
BUY
$548.35 - $738.84 $548 - $738
1 Added 0.34%
298 $176 Million
Q1 2022

Mar 21, 2023
BUY
$595.12 - $698.43 $133,306 - $156,448
224 Added 75.42%
521 $364 Million
Q4 2021

Mar 21, 2023
BUY
$543.48 - $670.97 $11,413 - $14,090
21 Added 7.07%
318 $201 Million
Q3 2021

Mar 22, 2023
BUY
$574.03 - $680.96 $204,354 - $242,421
356 Added 119.87%
653 $395 Million
Q2 2021

Mar 22, 2023
BUY
$472.8 - $558.54 $56,263 - $66,466
119 Added 40.07%
416 $232 Million
Q1 2021

Mar 22, 2023
BUY
$446.73 - $548.2 $1.08 Million - $1.33 Million
2,419 Added 814.48%
2,716 $1.29 Billion
Q4 2020

Mar 22, 2023
BUY
$478.3 - $607.98 $88,485 - $112,476
185 Added 62.29%
482 $233 Million
Q3 2020

Mar 22, 2023
BUY
$544.75 - $658.21 $150,351 - $181,665
276 Added 92.93%
573 $321 Million
Q2 2020

Mar 24, 2023
SELL
$493.32 - $643.92 $485,426 - $633,617
-984 Reduced 40.31%
1,457 $909 Million
Q1 2020

Mar 24, 2023
BUY
$336.18 - $494.43 $720,769 - $1.06 Million
2,144 Added 721.89%
2,441 $1.19 Billion
Q4 2019

Mar 24, 2023
SELL
$274.13 - $376.51 $42,764 - $58,735
-156 Reduced 52.53%
141 $52.9 Million
Q3 2019

Mar 24, 2023
SELL
$273.46 - $318.39 $1,914 - $2,228
-7 Reduced 5.22%
127 $35.2 Million
Q2 2019

Mar 24, 2023
SELL
$299.6 - $414.82 $48,834 - $67,615
-163 Reduced 54.88%
134 $41.9 Million
Q1 2019

Mar 24, 2023
BUY
$372.08 - $439.57 $56,184 - $66,375
151 Added 139.81%
259 $106 Million
Q4 2018

Mar 24, 2023
SELL
$335.82 - $403.04 $36,268 - $43,528
-108 Reduced 50.0%
108 $40.3 Million
Q3 2018

Mar 24, 2023
SELL
$351.14 - $408.51 $28,442 - $33,089
-81 Reduced 27.27%
216 $87.3 Million
Q1 2018

Mar 24, 2023
SELL
$315.82 - $393.78 $56,847 - $70,880
-180 Reduced 60.61%
117 $40.3 Million
Q4 2017

Mar 24, 2023
SELL
$358.63 - $469.95 $74,236 - $97,279
-207
90 $33.8 Million

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email